Overview
- Class A shares of the fund outpaced the Russell 2000 Growth Index in Q4 2025, with Utilities and Financials aiding results while Consumer Discretionary and Information Technology weighed on performance.
- Alger reports a firm Q4 backdrop for U.S. equities, citing a 2.7% S&P 500 gain supported by stronger earnings, a more accommodative Federal Reserve stance, resilient economic data, and clearer trade policy.
- Exact Sciences was a positive contributor after Abbott announced a definitive all-cash agreement to acquire the company for about $21 billion in equity value, boosting the stock.
- Market data show Exact Sciences closed at $102.43 on January 16, 2026 with a one-month return of 0.60%, a 52-week gain of 97.97%, and a market capitalization of $19.453 billion.
- Alger flags growing doubts about AI enthusiasm due to bottlenecks, financing pressures, and uncertain returns, and it also cites Natera’s gains following stronger-than-expected results and raised 2025 guidance.